Wells Fargo analyst Gabe Hajde raised the firm’s price target on AptarGroup to $152 from $140 and keeps an Overweight rating on the shares. The firm notes AptarGroup’s investor day showcased its strong Pharma outlook with multiple conversion and growth opportunities, in addition to focusing on operational improvements across its core businesses. Wells came away incrementally more constructive on long-term prospects.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ATR: